Copyright
©The Author(s) 2021.
World J Diabetes. Mar 15, 2021; 12(3): 292-305
Published online Mar 15, 2021. doi: 10.4239/wjd.v12.i3.292
Published online Mar 15, 2021. doi: 10.4239/wjd.v12.i3.292
Table 5 Results of intention-to-treat analysis for primary and secondary outcomes
| Variable | Baseline | 2 mo | 6 mo | 12 mo | Significance level | ||||||
| CBT | Control | CBT | Control | CBT | Control | CBT | Control | Condition | Time | Interaction | |
| PSQI score | 10.07 (2.38) | 10.04 (2.37) | 9.36 (2.77) | 9.92 (2.44) | 9.45(2.75) | 9.95 (2.59) | 9.07 (2.69) | 9.94 (2.40) | < 0.001 | < 0.001 | < 0.001 |
| HbA1c value | 7.44 (1.12) | 7.50 (1.11) | 7.46 (1.10) | 7.49 (1.15) | 7.27 (1.18) | 7.44 (1.20) | 7.23 (1.17) | 7.61 (1.16) | < 0.001 | 0.028 | < 0.001 |
- Citation: Zhang HZ, Zhang P, Chang GQ, Xiang QY, Cao H, Zhou JY, Dong ZM, Qiao C, Xu CR, Qin Y, Lou PA. Effectiveness of cognitive behavior therapy for sleep disturbance and glycemic control in persons with type 2 diabetes mellitus: A community-based randomized controlled trial in China. World J Diabetes 2021; 12(3): 292-305
- URL: https://www.wjgnet.com/1948-9358/full/v12/i3/292.htm
- DOI: https://dx.doi.org/10.4239/wjd.v12.i3.292